...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Something "Material" is happening

CCD not purely an acedemic victory. COVID - 19 will be with us for years to come and therapeutic ABL will be needed for years to come as I understand it. 

1) Apabetalone treatment reduces SARS-CoV-2 infectivity and completely prevents cardiac damage in a cytokine-storm model

2) Apabetalone Treatment Prevents COVID-19 Infection of Human Lung Cell 

 

Koo

Share
New Message
Please login to post a reply